PreCare Trial & Recruitment B.V.
- Address
- Kasteelhof 5, 6121 XK Beek Lb, The Netherlands
Cardiovascular Research
At PreCare Trial & Recruitment B.V. the focus is on cardiovascular research. The centre studies atherosclerotic cardiovascular disease and related risk factors. It also investigates elevated Lp(a) as a target for new therapies. Patients with type 2 diabetes and hypertension are included to evaluate cardiovascular outcomes.
- Combination therapy with vicadrostat and empagliflozin
- Muvalaplin for reducing major adverse cardiovascular events
- Evaluation of cardiovascular outcomes in high‑risk patients
These studies aim to improve prevention and management of heart disease and associated metabolic conditions.
Immune System Research
The site conducts research into immune system disorders. A key focus is rheumatoid arthritis, testing innovative treatments. Comparisons with existing biologics aim to reduce the risk of venous thromboembolism.
- Baricitinib versus TNF inhibitors for venous thromboembolism risk
- Assessment of disease activity improvement in rheumatoid arthritis
The goal is to expand therapeutic options for autoimmune patients while monitoring vascular safety.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Novo Nordisk A/S2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +6 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in PreCare Trial & Recruitment B.V.
lock Showing 1 of 14 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, 24-week, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Ignite) | Amgen Inc. | Phase III | Not Recruiting | Apr 2023 | Sep 2024 |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BI 456906 | 2 | Unknown | 2024-01-18 | 2024-01-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.